STAT

AUGUST 17, 2024

It’s been a hard week for the psychedelics pioneer Rick Doblin.  First, the Food and Drug Administration declined to approve the MDMA-assisted therapy for post-traumatic stress disorder developed by Lykos Therapeutics, a company that he founded. The next day, the journal Psychopharmacology retracted three studies on the treatment, in which many authors were associated with Lykos or the nonprofit Doblin founded, the Multidisciplinary Association for Psychedelic Studies (MAPS).

FDA 144

FDA 144

Pharmacy Times

AUGUST 17, 2024

New payment frameworks are emerging, but pharmacists need to be central to the ongoing food as medicine movement.

145

145

STAT

AUGUST 17, 2024

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

FDA 105

FDA 105

Drug Topics

AUGUST 17, 2024

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

98

98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

AUGUST 17, 2024

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

Community Pharmacies 81

Community Pharmacies 81

Drug Topics

AUGUST 17, 2024

Check out this recap of articles published on our sister sites during the past week.

98

98

Drug Topics

AUGUST 17, 2024

Sustainable pharmacy partnerships require addressing financial, technology, and customer needs.

94

94

The Checkup by Singlecare

AUGUST 17, 2024

Clonazepam is a prescription benzodiazepine, a class of drugs that slows down the nervous system. Also sold as brand-name Klonopin , veterinarians use clonazepam in dogs as an add-on treatment for seizures and use it alone to reduce anxiety in the dog. It may have other uses, such as a muscle relaxant or a sleep aid. Clonazepam is safe for dogs when given as recommended, but long-term therapy can cause dependence, tolerance, and withdrawal when it’s stopped.

Dosage 52

Dosage Controlled Substances Labelling Hospitals 52

BioPharm

AUGUST 17, 2024

Imfinzi may be used alone, or with chemotherapy in tandem with the other approved treatment, Lynparza.

Chemotherapy 52

Chemotherapy 52

Therapeutics Education Collaboration

AUGUST 17, 2024

In episode 582, Mike and James go over the issues associated with using CVD risk calculators. We talk about where the numbers come from, what they mean, what their limitations are, how to think about them and how to use them. So have a listen as it may decrease your risk but it will definitely increase your understanding. Show notes 1) PEER Simplified Cardiovascular Decision Aid [link] 2) Incorporation of Shared Decision-Making in International Cardiovascular Guidelines, 2012-2022 JAMA Network O

Hospitals 52

Hospitals 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Guardian - Pharmaceutical Industry

AUGUST 17, 2024

Health leaders warn that global response to virus is test case for equity and preparation for future pandemics A failure to show solidarity with African countries at the heart of the mpox outbreak will put the world at risk and harm preparations for future pandemics, health leaders have said. The World Health Organization on Wednesday declared an international public health emergency in the face of rising cases that are spreading beyond the Democratic Republic of the Congo (DRC), where the virus

110

110